Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats

Journal of Hypertension

Volumn 15, Issue 6, 1997, Pages 643-650

  Jandeleit Dahm, Karin ^a   Burrell, Louise M ^b   Johnston, Colin I ^b   Koch, Karl M ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin converting enzyme; Angiotensin II; Angiotensin II receptor antagonism; Balloon angioplasty; Hypertension; Neointima; Restenosis

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA WALL; ARTICLE; BLOOD PRESSURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FOGARTY CATHETER; INTIMA; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; TUNICA MEDIA;

EID: 0030947563     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715060-00011     Document Type: Article

References (38)

1. McBride W, Lange RA, Hillis LD: Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N Engl J Med 1988, 18:1734-1737.
2. MacDonald RG, Henderson MA, Hirshfeld JW, Goldberg SH, Bass T, Vetrovec G, et al.: Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty: a report from the M-HEART group. Am J Cardiol 1990, 66:926-931.
3. Clowes AW, Reidy MA, Clowes MM: Mechanisms of stenosis after arterial injury. Lab Invest 1983, 49:208-215.
4. Dzau VJ, Pratt RE: Tissue renin angiotensin system in experimental restenosis after vascular injury: evidence for local activation. J Cardiovasc Pharmacol 1992, 20 (suppl B):S28-S32.
5. Rakugi H, Jacob HI, Krieger JE, Ingelfinger JR, Pratt RE: Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation 1993, 87:283-290.
6. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE: Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994, 93:339-346.
7. Fishel NS, Thourani V, Eisenberg SJ, Shai SY, Corson MA, Nabel EG, et al.: Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. J Clin Invest 1995, 95:377-387.
8. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, et al.: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989, 245:186-188.
9. Rakugi H, Wang DS, Dzau VJ, Pratt RE: Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation, 1994, 90:449-455.
10. Kauffman RF, Bean JS, Zimmerman KM, Brown RF, Steinberg MI: Losartan, a nonpeptide angiotensin II (ANGII) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci 1991, 49:PL223-PL228.
11. Kawamura M, Terashita Z, Okuda H, Imura Y, Shino A, Nakan M, et al.: TCV 116, a novel angiotensin II receptor antagonist prevents intimai thickening and impairment of vascular function after carotid injury in rats. J Pharmacol Exp Ther 1993, 266:1664-1669.
12. Osterrieder W, Muller RKM, Powell JS, Clozel JP, Hefti F, Baumgartner HR: Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 1991, 18 (suppl):II60-II64.
13. Popma JJ, De Cesare NB, Pinkerton CA, Kereiakes DJ, Whitlow P, King SB 3d, et al.: Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomy. Am J Cardiol 1993, 71:552-557.
14. Volteas N, Labropoulos N, Leon M, Kalodidi E, Chan P, Nicolaides AN: Risk factors associated with recurrent carotid artery stenosis. Int Angiol 1994, 13:143-147.
15. Clowes AW, Clowes MM: Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats. Lab Invest 1980, 43:535-541.
16. Clowes AW, Clowes MM: The influence of hypertension on injury-induced myointimal thickening. Surgery, 1980, 88:254-259.
17. Sun Y, Mendelsohn FAO: Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. J Cardiovasc Pharmacol 1991, 18:478-486.
18. Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, Wexler RR, et al.: In vivo pharmacology of DuP 753. Am J Hypertens 1991, 4:288S-298S.
19. Bunag RD: Validation in awake rats of tail-cuff method for measuring systolic pressure. J Appl Physiol 1973, 34:279-282.
20. 125 I-labelled 351A. Clin Exp Pharmacol Physiol 1984, 11:431-436.
21. Johnston CI: Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994, 23:258-268.
22. Shiota N, Miyazaki M, Okunishi H: Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension 1992, 20:168-174.
23. Nakamura Y, Nakamura K, Matsukura T, Nakamura K: Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril. J Hypertens 1988, 6:105-110.
24. Paquet JL, Baudonin-Legros M, Brunelle G, Meyer P: Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1990, 8:565-572.
25. Taguchi J, Abe J, Okazti H, Ochini M, Ohno M, Takuwa Y, et al.: Angiotensin converting enzyme inhibitors or Dup753 prevent neointimal formation following balloon injury with single topical or multiple systemic application. Biochem Biophys Res Commun 1993, 196:969-974.
26. Clozel W, Muller RKM, Roey S, Fischli W, Baumgartner HR: Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats. Circulation 1993, 88:1222-1227.
27. deBlois D, Lombardi DM, Garvin MA, Schwartz SM: Inhibition by ramipril of intimal hyperplasia in the denuded rat carotid is reversed by Hoe 140, a kinin B2 receptor antagonist [abstract]. Circulation 1992, 86:1226.
28. Farhy RD, Carretero OA, Ho KL, Scicli G: Role of kinins and nitric oxide in the effects of ACE inhibition on neointima formation. Circ Res 1993, 72:1202-1210.
29. Itoh H, Mukoyarna M, Pratt RE, Gibbons GH, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993, 91:2268-2274.
30. Naftilan AJ, Pratt RE, Dzau VI: Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83:1419-1424.
31. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW: Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992, 89:507-511.
32. Kim SH, Kawamura M, Wanibuchi H, Ohta K, Hamaguchi A, Omura T, et al.: Angiotensin II type I receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation 1995, 92:88-95.
33. MERCATOR Study: Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR Study: a multicenter, randomized double blind placebo controlled trial. Circulation 1992, 86:100-110.
34. Faxon DO, on behalf of the MARCATOR Study Group. Effect of high dose ACE inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo controlled trial for cilazapril. Am J Coll Cardiol 1995, 2:362-369.
35. Omoigni N, Dzau VJ: Differential effects of antihypertensive agents in experimental and human atherosclerosis. Am J Hypertens 1993, 6:30S-39S.
36. Clozel JP, Powell JS, Kuhn H, Muller RKM, Hefti F, Baumgartner HR: Vascular protection with cilazapril. Drugs 1991, 41 (suppl 1): 62-67.
37. Capron L, Heudes D, Chijara A, Bruneval P: Effect of ramipril, an inhibitor of angiotensin converting enzyme on the response of rat thoracic aorta to injury with a balloon catheter. J Cardiovasc Pharmacol 1991, 18:207-211.
38. Hanson SR, Powell JS, Dodson T, Lunssden A, Kelly AB, Anderson JS, et al.: Effects of angiotensin converting enzyme inhibition with cilazapril on intimai hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 1991, 18 (suppl II):II70-II76.